Clinical Trial Update: Radiotherapy Plus Xevinapant in Older Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial of radiotherapy plus Xevinapant for older patients with locally advanced head and neck squamous cell carcinoma has been suspended; no trial result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Xevinapant (Xevinapant)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: SUSPENDED